Why the study?
Does oral trimetazidine reduce periprocedural myocardial injury in patients with stable angina undergoing elective PCI?
Does oral trimetazidine reduce periprocedural myocardial injury in patients with stable angina undergoing elective PCI?
Pre-treatment with oral trimetazidine for 7 days before elective PCI significantly reduces periprocedural myocardial injury as measured by lower troponin I levels and improved TIMI flow.
No takes yet. Share an insight, caveat, or question.
Trimetazidine was associated with lower post-PCI cTnI; hypothesis-generating and should not change practice.
Kazmi et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: